Page 3 - Although Abivax News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Although abivax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Although Abivax Today - Breaking & Trending Today

Abivax adjusts its 2023 Financial Communication Calendar

EQS-News: ABIVAX / Key word(s): MiscellaneousAbivax adjusts its 2023 Financial Communication Calendar 16.03.2023 / 18:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax adjusts its 2023 Financial Communication CalendarPARIS, France, March 16, 2023 – 06:30 p.m. (CET) – Abivax SA (. ....

France General , Enregistrement Universel , Financial Communications Calendar , Distribution Services , Communication Calendar , Euronext Paris , Communications Calendar , Abivax Board , General Assembly , Truffle Capital , Although Abivax , French Autorit , Des March , Corporate News , Regulatory Announcements ,

Abivax publishes novel data with respect to obefazimod's anti-inflammatory mechanism of action

EQS-News: ABIVAX / Key word(s): Scientific publicationAbivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action 05.01.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax publishes novel data with respect to obefazimod’s anti-inflammat. ....

France General , Hartmutj Ehrlich , Enregistrement Universel , Distribution Services , Translational Gastroenterology , Euronext Paris , United States , Truffle Capital , Although Abivax , French Autorit , Des March , Corporate News , Regulatory Announcements ,

Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD

EQS-News: ABIVAX / Key word(s): StudyAbivax receives FDA agreement on pediatric development plan with obefazimod in IBD 20.12.2022 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax receives FDA agreement on pediatric development plan with obefazimod in IBDThe FDA agreed on. ....

France General , Hartmutj Ehrlich , Enregistrement Universel , Drug Administration , Distribution Services , Pediatric Study Plan , Euronext Paris , United States , Truffle Capital , Although Abivax , French Autorit , Des March , Corporate News , Regulatory Announcements ,